Compugen (CGEN) Beats Q4 Earnings and Revenue Estimates

分组1 - Compugen reported quarterly earnings of $0.6 per share, significantly exceeding the Zacks Consensus Estimate of $0.05 per share, and compared to a loss of $0.07 per share a year ago, representing an earnings surprise of +1,053.85% [1] - The company posted revenues of $67.33 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 276.79%, compared to year-ago revenues of $1.47 million [2] - Compugen shares have increased approximately 18.3% since the beginning of the year, outperforming the S&P 500's gain of 0.5% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$0.08 on revenues of $2.5 million, and for the current fiscal year, it is -$0.21 on revenues of $29.88 million [7] - The Medical - Biomedical and Genetics industry, to which Compugen belongs, is currently ranked in the top 36% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Compugen has a Zacks Rank of 3 (Hold), suggesting that the shares are expected to perform in line with the market in the near future [6]